14 Hospital Physician Board Review Manual www.turner-white.com
34. Lechapt E, Habibi A, Bachir D, et al. Induced sputum
versus bronchoalveolar lavage during acute chest syndrome in sickle cell disease. Am J Respir Crit Care Med
35. Godeau B, Schaeffer A, Bachir D, et al. Bronchoalveolar
lavage in adult sickle cell patients with acute chest syndrome: value for diagnostic assessment of fat embolism.
Am J Respir Crit Care Med 1996;153:1691–6.
36. Feldman L, Gross R, Garon J, et al. Sickle cell patient with
an acute chest syndrome and a negative chest X-ray: potential role of the ventilation and perfusion (V/Q) lung scan.
Am J Hematol 2003;74:214–5.
37. Kaur N, Motwani B, Sivasubramaniam D, et al. Potential
role of the ventilation and perfusion (V/Q) lung scan in the
diagnosis of acute chest syndrome in adults with sickle cell
disease. Am J Hematol 2004;77:407–9.
38. Haynes J Jr, Allison RC. Pulmonary edema. Complication
in the management of sickle cell pain crisis. Am J Med
39. Kopecky EA, Jacobson S, Joshi P, Koren G. Systemic exposure to morphine and the risk of acute chest syndrome
in sickle cell disease. Clin Pharmacol Ther 2004;75:140– 6.
40. Koch J, Manworren R, Clark L, et al. Pilot study of continuous co-infusion of morphine and naloxone in children with
sickle cell pain crisis. Am J Hematol 2008;83:728–31.
41. van Beers EJ, van Tuijn CF, Nieuwkerk PT, et al. Patient
controlled analgesia versus continuous infusion of morphine during vaso-occlusive crisis in sickle cell disease,
a randomized controlled trial. Am J Hematol 2007;82:
42. Phillips WJ, Gadiraju S, Dickey S, et al. Dexmedetomidine
relieves pain associated with acute sickle cell crisis [letter].
J Pain Symptom Manage 2007;34:346–9.
43. Robieux IC, Kellner JD, Coppes MJ, et al. Analgesia in
children with sickle cell crisis: comparison of intermittent
opioids vs. continuous intravenous infusion of morphine
and placebocontrolled study of oxygen inhalation. Pediatr
Hematol Oncol 1992;9:317–26.
44. Zipursky A, Robieux IC, Brown EJ, et al. Oxygen therapy in sickle cell disease. Am J Pediatr Hematol Oncol
45. Bendixen HH, Smith GM, Mead J. Pattern of ventilation in
young adults. J Appl Physiol 1964;19:195–8.
46. Boyd JH, Macklin EA, Strunk RC, DeBaun MR. Asthma is
associated with acute chest syndrome and pain in children
with sickle cell anemia. Blood 2006;108:2923–7.
47. Bryant R. Asthma in the pediatric sickle cell patient with acute
chest syndrome. J Pediatr Health Care 2005;19:157–62.
48. Martí-Carvajal AJ, Conterno LO, Knight-Madden JM. Antibiotics for treating acute chest syndrome in people with
sickle cell disease. Cochrane Database Syst Rev 2013
49. Bernini JC, Rogers ZR, Sandler ES, et al. Beneficial effect of intravenous dexamethasone in children with mild
to moderately severe acute chest syndrome complicating
sickle cell disease. Blood 1998;92:3082–9.
50. Isaacs WA, Effiong CE, Ayeni O. Steroid treatment in the
prevention of painful episodes in sickle-cell disease. Lancet 1972;1:570– 1.
51. Strouse JJ, Hulbert ML, DeBaun MR, et al. Primary hemorrhagic stroke in children with sickle cell disease is associated with recent transfusion and use of corticosteroids.
52. Strouse JJ, Takemoto CM, Keefer JR, et al. Corticosteroids
and increased risk of readmission after acute chest syndrome in children with sickle cell disease. Pediatr Blood
53. Firth PG, Tsuruta Y, Kamath Y, et al. Transfusion-related
acute lung injury or acute chest syndrome of sickle cell
disease? A case report. Can J Anaesth 2003;50:895–9.
54. Wayne AS, Kevy SV, Nathan DG. Transfusion management of sickle cell disease. Blood 1993;81:1109–23.
55. Lombardo T, Rosso R, La Ferla A, et al. Acute chest syndrome: the role of erythro-exchange in patients with sickle
cell disease in Sicily. Transfus Apher Sci 2003;29:39–44.
56. Liem RI, O’Gorman MR, Brown DL. Effect of red cell exchange transfusion on plasma levels of inflammatory mediators in sickle cell patients with acute chest syndrome.
Am J Hematol 2004;76:19–25.
57. Cox JV, Steane E, Cunningham G, et al. Risk of alloimmunization and delayed hemolytic transfusion reactions
in patients with sickle cell disease. Arch Intern Med
58. Rosse WF, Gallagher D, Kinney TR, et al. Transfusion and
alloimmunization in sickle cell disease. The cooperative
study of sickle cell disease. Blood 1990;76:1431–7.
59. Aygun B, Padmanabhan S, Paley C, Chandrasekaran V.
Clinical significance of RBC alloantibodies and autoanti-bodies in sickle cell patients who received transfusions.
60. Davies SC, McWilliam AC, Hewitt PE, et al. Red cell
alloimmunization in sickle cell disease. Br J Haematol
61. Vichinsky EP, Earles A, Johnson RA, et al. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. N Engl J Med 1990;322:1617–21.
62. Qari MH, Aljaouni SK, Alardawi MS, et al. Reduction of
painful vaso-occlusive crisis of sickle cell anaemia by
tinzaparin in a double-blind randomized trial. Thromb Hae-most 2007;98:392–6.
63. Ballas SK, Files B, Luchtman-Jones L, et al. Safety of purified poloxamer 188 in sickle cell disease: phase I study of